Current Rheumatology Reports

Papers
(The TQCC of Current Rheumatology Reports is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-01-01 to 2025-01-01.)
ArticleCitations
Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms105
Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response96
Trabecular Bone Score in Rheumatic Disease84
Emerging Concepts in Precision Medicine in Axial Spondyloarthritis83
The Role of Environmental Factors in the Development of Idiopathic Inflammatory Myopathies: a Narrative Review62
Engineering Closed-Loop, Autoregulatory Gene Circuits for Osteoarthritis Cell-Based Therapies37
Decoding the Intricacies of Statin-Associated Muscle Symptoms36
Which Hormones and Contraception for Women with APS? Exogenous Hormone Use in Women with APS35
Updates on Clinical Trials in Systemic Lupus Erythematosus35
Narrative Review: Peripheral Arterial Disease in Patients with Hyperuricemia and Gout34
Exogenous miRNA: A Perspective Role as Therapeutic in Rheumatoid Arthritis34
Role of IFN-α in Rheumatoid Arthritis34
An Update on the Diagnosis and Management of Calcium Crystal Disease32
The Microbiome in Osteoarthritis: a Narrative Review of Recent Human and Animal Model Literature31
An Open Debate on the Morphological Measurement Methodologies of the Infrapatellar Fat Pad to Determine Its Association with the Osteoarthritis Process30
Novel Therapies for ANCA-associated Vasculitis30
Clinical Approach to Diagnosis and Therapy of Polyarteritis Nodosa29
Sequence of Events in the Pathogenesis of Axial Spondyloarthritis: A Current Review—2023 SPARTAN Meeting Proceedings29
Cannabis for Rheumatic Disease Pain: a Review of Current Literature26
Clinical Characteristics of Myositis Associated with Graft-Versus-Host Disease26
Re-Examining Myofascial Pain Syndrome: Toward Biomarker Development and Mechanism-Based Diagnostic Criteria26
Updating the 2019 ACR/SAA/SPARTAN Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis (SPARTAN 2024 Annual Meeting Proceedings)25
Oral Versus Subcutaneous Methotrexate in Immune-Mediated Inflammatory Disorders: an Update of the Current Literature24
Is There Still a Role of Plasma Exchange in the Current Management of ANCA-Associated Vasculitides?24
Checkpoint Molecules in Rheumatology—or the Benefits of Being Exhausted23
Update on Biomarkers of Vasculopathy in Juvenile and Adult Myositis22
Machine Learning Approaches to the Prediction of Osteoarthritis Phenotypes and Outcomes22
Enzymatic Machinery of Ubiquitin and Ubiquitin-Like Modification Systems in Chondrocyte Homeostasis and Osteoarthritis21
Mesangial Cells in Lupus Nephritis21
Future of Low-Dose Computed Tomography and Dual-Energy Computed Tomography in Axial Spondyloarthritis21
Telemedicine for the Care of Patients with Idiopathic Inflammatory Myopathies: Experience, Insights and Future Directions from the International Myositis Assessment and Clinical Studies Telemedicine S21
Pipeline Therapies for Gout21
Imaging of Joint and Soft Tissue Involvement in Systemic Lupus Erythematosus21
Intersections Between Mitochondrial Metabolism and Redox Biology Mediate Posttraumatic Osteoarthritis20
Effect of Osteoporosis Treatments on Osteoarthritis Progression in Postmenopausal Women: A Review of the Literature20
Current Epidemiology and Risk Factors for the Development of Hand Osteoarthritis19
Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update18
Systemic Lupus Erythematosus in Children and Young People18
Correction to: Have Therapeutics Enhanced Our Knowledge of Axial Spondyloarthritis?18
Advancements in Imaging Techniques for Early Diagnosis and Management of Axial Spondyloarthritis18
Immune Checkpoint Inhibitor Associated Rheumatoid Arthritis18
Epidemiology of Antiphospholipid Syndrome in the General Population17
Kidney Failure in Pauci-immune Crescentic Glomerulonephritis: Rationale for Immunosuppression to Improve Kidney Outcome17
Calcium Pyrophosphate Crystal Deposition: Insights to Risks Factors and Associated Conditions17
Treatment of Calcinosis in Juvenile Dermatomyositis16
Interstitial Pneumonia with Autoimmune Features: What the Rheumatologist Needs to Know16
Do Disease-Modifying Anti-rheumatic Drugs and Exercise Therapy Have a Combined Effect on Disease Activity in Patients with RA? A Scoping Review15
Metabolic Regulation of Tendon Inflammation and Healing Following Injury15
Updates on the Immunopathology in Idiopathic Inflammatory Myopathies15
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia15
Calcinosis in Juvenile Dermatomyositis—Epidemiology, Pathogenesis, Clinical Features, and Treatment: A Systematic Review15
Deep Insight into the Role of MIF in Spondyloarthritis14
The Use of COVID-19 Vaccines in Patients with SLE14
Interstitial Lung Disease in ANCA-Associated Vasculitis: Pathogenic Considerations and Impact for Patients’ Outcomes14
Use of Imaging in Axial Spondyloarthritis for Diagnosis and Assessment of Disease Remission in the Year 202214
AA Amyloidosis: A Contemporary View14
Who Would Have Predicted Multisystem Inflammatory Syndrome in Children?14
Air Pollution and Rheumatoid Arthritis Risk and Progression: Implications for the Mucosal Origins Hypothesis and Climate Change for RA Pathogenesis14
0.031331062316895